Literature DB >> 18358197

[B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy].

I Hernández1, O Sanmartín, C Cardá, S Góme, A Alfaro.   

Abstract

Aluminium hydroxide is used as an adjuvant in vaccines. We describe the case of a patient who presented a persistent adverse local reaction to aluminium hydroxide due to hyposensitization therapy to dust mites. Multiple painful and pruriginous subcutaneous nodules were observed in both arms, along with hypertrichosis at the injection site. Histology revealed a pseudolymphomatous B cell reaction predominantly involving cells that were CD20 positive, did not express bcl-2, and did not display the t(14-18) translocation. The cells also exhibited polyclonal rearrangement of the immunoglobulin heavy chains. X-ray spectral microanalysis revealed deposits of inorganic aluminium in the granular histiocytes among the germinal centers. The patient was diagnosed with cutaneous B-cell pseudolymphoma due to aluminium hydroxide as a result of immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18358197

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  2 in total

Review 1.  Adjuvants and lymphoma risk as part of the ASIA spectrum.

Authors:  Dana Butnaru; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  Sonography of subcutaneous nodules following immunization with histopathological correlation: a three-case series.

Authors:  Ana María González Pérez; Laura Nájera Botello; Dolores Suarez Massa; Gastón Roustan Gullón; Fernando Alfageme Roldán
Journal:  J Ultrasound       Date:  2021-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.